Delivery Order SPE2DB22D1106-SPE2DB25FFBF0
- Not listed
- The Defense Logistics Agency awarded a $1,046.29 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 capsules of Cefdinir 300 mg, an oral antibiotic commonly used to treat bacterial infections. This delivery order was competitively awarded with no set-aside designation and carries an ultimate completion date of July 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Cefdinir 300 mg capsules (60-count units) with a ceiling value of $1,839.68. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 21, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The contract represents no set-aside designation and is issued as a child order under a larger contract...
- The Defense Logistics Agency (DLA) awarded a $7,804 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,559,492,739 units of the pharmaceutical drug Cefdinir 300 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 300 mg Cefdinir capsules, with a ceiling value of $1,062.45 and a completion date of July 17, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific program or business type. AmerisourceBergen Drug Corp holds a substantial...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,591.67 firm fixed-price delivery order is for the supply of 4,567,792 capsules of the drug Cefdinir 300 mg. The contract has an ultimate completion date of April 4, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
- This federal contract award, valued at $1,507.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,561,119,982 units of Cefdinir 300 mg capsules in quantities of 60s. This is a firm fixed-price delivery order contract, with a completion date of June 5, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,310 to Amerisourcebergen Drug Corporation to supply 60 capsules of the antibiotic cefdinir. Performance will take place in Conshohocken, Pennsylvania over a period of three days from July 7 through July 10, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor in fulfilling this order to supply pharmaceutical...
- The Defense Logistics Agency awarded a $1,922.24 delivery order to Amerisourcebergen Drug Corporation for 60 capsules of the antibiotic cefdinir. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania to support Defense Logistics Agency programs. No subcontractors or set aside designations were identified. The order was placed under an existing DLA pharmaceuticals contract vehicle and will provide needed antibiotic supplies from August 21-22,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,320.61 firm fixed-price delivery order is for the supply of 4562262625 - CEFDINIR 300 MG CAPSULE 60S, with a completion date of September 22, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
- The Defense Logistics Agency Troop Support Medical awarded a $56,100 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100mL bottles of the antibiotic cefdinir suspension. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by August 1, 2023 to support DLA's mission of providing...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFBF0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,555.75 to AmerisourceBergen Drug Corp for 60 capsules of Cefdinir 300 mg, a commonly prescribed oral antibiotic. The contract is a firm fixed price delivery order with an ultimate completion date of August 4, 2025, and was awarded on August 2, 2025. No set-aside designation was used for this competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. That overarching contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceuticals and medical supplies to military healthcare programs worldwide. The company's extensive federal pharmaceutical portfolio demonstrates its established capability to meet Department of Defense medical procurement requirements across multiple therapeutic domains and delivery scales.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 8/2/25 |